Liston Dorion, Wong Katherine, Yeoh Aaron, Haywood Shalonda, Goel Aparna, Kwo Paul, Kennedy Quinn, Okafor Philip N
neuroFit, Inc., Mountain View, CA 94040, USA.
Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
Geriatrics (Basel). 2025 Aug 19;10(4):112. doi: 10.3390/geriatrics10040112.
Hepatic encephalopathy (HE) occurs in 20-80% of patients with liver cirrhosis, impacting attention, memory, processing speed, and visuospatial skills. HE standard-of-care psychometric assessments are time-consuming and require staff training. Oculometrics may provide a fast, non-invasive brain health assessment that can be self-administered in a medical environment.
We investigated whether an oculometric assessment could measure the severity of HE as accurately as standard-of-care psychometric methods.
Forty-eight participants (19 with decompensated cirrhosis, 10 with compensated cirrhosis, 19 controls) completed a previously validated five-minute oculometric test and the standard-of-care psychometric hepatic encephalopathy (PHE) battery. The oculometric test consists of following a dot as it moves across a computer screen and generates 10 metrics including a summary score called nFit. The PHE battery entails five standard cognitive tests, generating seven metrics including a PHE composite score (PHES).
The oculometric summary score, nFit, correlated with the current diagnostic standard, the PHES ( = 0.51, < 0.001), the presence or absence of HE as determined by PHES composite ( = -0.44, < 0.001), as well as the severity of cirrhosis ( = -0.59, < 0.001). Additionally, performance on both nFit and PHES distinguished compensated (ROC: nFit: 0.71, PHES: 0.68) and decompensated (ROC: nFit: 0.88, PHES: 0.85) patient groups from control participants comparably. Finally, compared to participants with decompensated cirrhosis, control participants had better scores for almost all oculometrics: acceleration, catch-up saccade amplitude, proportion smooth, direction noise, and speed noise.
Patients with liver disease showed impairment on multiple aspects of visual processing compared to a control group. These functional visual processing impairments correlate with the presence or absence of HE, showing significant sensitivity in distinguishing people with HE from controls. Oculometric tests provide a quick, non-invasive functional assessment of brain health in patients with liver disease, with sensitivity indistinguishable from standard-of-case psychometric tests.
20%-80%的肝硬化患者会发生肝性脑病(HE),影响注意力、记忆力、处理速度和视觉空间技能。HE的标准护理心理测量评估耗时且需要工作人员培训。眼动测量法可能提供一种快速、非侵入性的脑健康评估方法,可在医疗环境中自行进行。
我们研究了眼动测量评估是否能像标准护理心理测量方法一样准确地测量HE的严重程度。
48名参与者(19名失代偿期肝硬化患者、10名代偿期肝硬化患者、19名对照组)完成了一项先前验证过的五分钟眼动测量测试和标准护理心理测量肝性脑病(PHE)成套测试。眼动测量测试包括跟踪一个在电脑屏幕上移动的点,并生成10个指标,包括一个名为nFit的综合得分。PHE成套测试包括五项标准认知测试,生成七个指标,包括一个PHE综合得分(PHES)。
眼动测量综合得分nFit与当前诊断标准PHES相关(r = 0.51,P < 0.001),与PHES综合得分确定的HE的有无相关(r = -0.44,P < 0.001),也与肝硬化的严重程度相关(r = -0.59,P < 0.001)。此外,nFit和PHES的表现同样能将代偿期(ROC:nFit:0.71,PHES:0.68)和失代偿期(ROC:nFit:0.88,PHES:0.85)患者组与对照组区分开来。最后,与失代偿期肝硬化患者相比,对照组在几乎所有眼动测量指标上得分更高:加速度、追赶扫视幅度、平稳比例、方向噪声和速度噪声。
与对照组相比,肝病患者在视觉处理的多个方面存在损害。这些功能性视觉处理损害与HE的有无相关,在区分HE患者与对照组方面表现出显著的敏感性。眼动测量测试为肝病患者提供了一种快速、非侵入性的脑健康功能评估,其敏感性与标准护理心理测量测试无异。